GNAS transcripts in skeletal progenitors: evidence for random asymmetric allelic expression of Gsα

S Michienzi, N Cherman, K Holmbeck… - Human molecular …, 2007 - academic.oup.com
S Michienzi, N Cherman, K Holmbeck, A Funari, MT Collins, P Bianco, PG Robey
Human molecular genetics, 2007academic.oup.com
Activating mutations of the Gsα gene, encoded by the guanine nucleotide-binding protein,
alpha stimulating (GNAS) locus located on chromosome 20q13, underlie different clinical
phenotypes characterized by skeletal lesions [fibrous dysplasia (FD) of bone], extraskeletal
diseases (mainly endocrine hyperfunction and skin hyperpigmentation) and variable
combinations thereof [the McCune–Albright syndrome (MAS)]. This clinical heterogeneity is
commonly assumed to reflect the post-zygotic origin of the mutation. However, the pattern of …
Abstract
Activating mutations of the Gsα gene, encoded by the guanine nucleotide-binding protein, alpha stimulating ( GNAS ) locus located on chromosome 20q13, underlie different clinical phenotypes characterized by skeletal lesions [fibrous dysplasia (FD) of bone], extraskeletal diseases (mainly endocrine hyperfunction and skin hyperpigmentation) and variable combinations thereof [the McCune–Albright syndrome (MAS)]. This clinical heterogeneity is commonly assumed to reflect the post-zygotic origin of the mutation. However, the pattern of imprinting of the Gsα gene in some human post-natal tissues suggests that parental-dependent epigenetic mechanisms may also play a role in the phenotypic effect of the mutated GNAS genotype. FD lesions are generated by mutated clonogenic osteoprogenitors that reside, along with their normal counterparts, in FD bone marrow stroma. We analyzed the allelic expression pattern of Gsα and other GNAS alternative transcripts in the progeny of normal and mutated clonogenic stromal cells isolated in vitro from a series of informative FD/MAS patients. We report here for the first time that the two Gsα alleles are unequally expressed in both normal and FD-mutated stromal clones. However, in contrast to imprinting, the ratio of Gsα allelic expression is randomly established in different clones from the same patient. This result suggests that a parental-independent modulation of Gsα expression occurs in clonogenic osteoprogenitor cells and, at the single cell level, may impact on the severity of an FD lesion. Furthermore, we show that normal and mutated clonogenic stromal cells express GNAS alternative transcripts other than the common Gsα, some of which may be relevant to the development of FD.
Oxford University Press